Cricopharyngeal Dysfunction in Adults
- Conditions
- Upper Esophageal Sphincter
- Registration Number
- NCT03598933
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The objective of the study, after reviewing the recent literature, is to corroborate the thesis of the authors considering the injection of botulinum toxin as a gesture that is both diagnostic and therapeutic in the disorders of the Upper Esophageal Sphincter and reinforce the results already published with a larger series of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Man or woman whose age older than 18 years
- Dysphagia with solids and / or liquids
- Dysfunction of primary or secondary Upper Esophageal Sphincter with indirect video-fibroscopy and / or video-fluoroscopy and / or high resolution pharyngo-oesophageal manometry
- Subject having at least one injection of botulinum toxin A in the crico-pharyngeal muscle for Upper Esophageal Sphincter dysfunction in the ENT department and cervico-facial surgery of Hautepierre.
- Subject who has consented to the use of his data from his medical file for the purpose of this research
Exclusion Criteria
- Myotomy in the first place
- Refusal of the subject to participate in the study
- Subject under the protection of justice
- Subject under guardianship or curatorship
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deglutition Handicap Index The period from January 1st, 2017 to December 31st, 2017 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service ORL et chirurgie cervico-faciale
🇫🇷Strasbourg, France